# Dietary and Dialysate Sodium Reduction on Body Fluid Volume and Inflammatory State in Hemodialysis Patients

> **NCT01458808** · PHASE4 · COMPLETED · sponsor: **UPECLIN HC FM Botucatu Unesp** · enrollment: 59 (actual)

## Conditions studied

- Chronic Kidney Diseases Stage 5

## Interventions

- **OTHER:** Dietary sodium restriction
- **OTHER:** Dialysate sodium concentration reduction

## Key facts

- **NCT ID:** NCT01458808
- **Lead sponsor:** UPECLIN HC FM Botucatu Unesp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2011-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458808, "Dietary and Dialysate Sodium Reduction on Body Fluid Volume and Inflammatory State in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01458808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*